Sarepta Therapeutics, Inc.

NASDAQ:SRPT

Biotechnology

Healthcare
$14.17 +1.71%

+$0.29 today

Market cap
$1.52B
Beta
0.20
P/E (TTM)
27.8
EPS (TTM)
$0.62
52W Low $10.42High $25.32

Volume 2.07M

Average 3.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$3.35B

FY 2025 · Annual

-15.5% YoY

Liabilities

$2.21B

FY 2025 · Annual

-9.3% YoY

Equity

$1.14B

FY 2025 · Annual

-25.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.12B966.78M428.43M1.1B801.28M
Short-term Investments01.02B1.25B251.78M138.37M
Net Receivables172.75M261.6M436.98M649.73M519.61M
Inventory186.21M203.97M322.86M749.96M914.74M
Other Current Assets5.3M6.82M12.48M9.21M9.2M
Total Current Assets2.6B2.56B2.58B3.07B2.54B
Property, Plant & Equipment (Net)236.69M244.99M357.11M488.65M470.62M
Goodwill00000
Intangible Assets14.24M7.58M29.62M26.89M28.95M
Long-term Investments34.89M31.32M6.53M136.87M1.05M
Tax Assets00000
Other Non-current Assets258.06M286.62M291.99M237.3M311.15M
Total Non-current Assets543.88M570.51M685.25M889.71M811.77M
Total Assets3.15B3.13B3.26B3.96B3.35B
Account Payables76.74M95.88M164.92M214.44M280.84M
Short-term Debt00105.48M00
Tax Payables216K12.52M13.77M17.39M0
Deferred Revenue89.24M89.24M50.42M130.26M443.4M
Other Current Liabilities110.44M134.73M178.81M200.28M176.13M
Total Current Liabilities452.73M619.6M653.66M731.68M1.1B
Long-term Debt1.1B1.54B1.13B1.14B828.97M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)574.24M485M437M325M83.91M
Other Non-current Liabilities54.6M36.94M41.1M49.15M1.53M
Total Non-current Liabilities1.77B2.12B1.75B1.7B1.11B
Total Liabilities2.22B2.74B2.41B2.44B2.21B
Common Stock9K9K9K10K11K
Retained Earnings(3.21B)(3.91B)(4.45B)(4.21B)(4.88B)
Accumulated OCI(20K)(1.66M)918K(218K)272K
Other Stockholders Equity00000
Minority Interest00000
Total Equity928.01M384.95M859.34M1.53B1.14B
Total Debt1.15B1.62B1.4B1.34B1.04B
Net Debt(962.43M)650.58M968.38M240.06M238.46M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$464.4M
Short-term Investments$188.7M
Receivables$547.9M
Inventory$1.0B
Other Current$107.7M
Total Current Assets$2.3B
PP&E (Net)$460.3M
Intangible Assets$31.4M
Long-term Investments$102.9M
Tax Assets$2.8M
Other Non-current$271.7M
Total Non-current Assets$869.1M
Total Assets$3.2B

Analysis

Selected assets total $3.2B for Latest. The largest visible component is Inventory at $1.0B, about 31.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
13F-HR13F-HR filingNov 13, 2026
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026

How much cash does SRPT have?

Sarepta Therapeutics, Inc. (SRPT) reported $801.28M in cash and equivalents in fiscal 2025.

How much debt does SRPT carry?

Sarepta Therapeutics, Inc. (SRPT) reported $1.04B of total debt, with net debt of $238.46M.